IndustryCompany release
Hydrofarm regains Nasdaq equity compliance after eliminating $109 million term loan
🇺🇸 Hydrofarm Holdings Group, Inc. (HYFM) · Thu 12 Nov 2026
Hydrofarm Holdings Group, a controlled-environment agriculture supplier and not a pharma company, said Nasdaq confirmed by letter dated November 9, 2026 that it again meets the $2.5 million minimum stockholders' equity rule. The confirmation followed the October 27 termination of its $109 million term loan, a registered direct offering and a concurrent private placement. The company still has to meet the minimum bid price requirement and remains under a mandatory panel monitor.
Company's press release (SEC filing): Hydrofarm Holdings Group, Inc. ↗
Brief written by VigiEye from the company's press release filed with the SEC. Claims are the company's own. AI-assisted; check the source before acting.
More Industry
All →
IM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M
IM Cannabis Corp. (IMCC) · Fri 13 Nov 2026
Helus Pharma, formerly Cybin, reports $150.9M six-month net loss as share compensation rises
Helus Pharma Inc. (HELP) · Fri 13 Nov 2026
IM Cannabis sells German arm to CEO-controlled Slil, refocusing on Israel
IM Cannabis Corp. (IMCC) · Fri 13 Nov 2026
DataMEDS AI Q3 revenue up 50% to $2.7M on GLP-1 dispensing
🇺🇸 DataMeds AI, Inc. (MEDS) · Fri 13 Nov 2026
Xenetic reports Q3 loss, advances all-stock Santersus deal and doses first DNase I CAR-T patient
🇺🇸 Xenetic Biosciences, Inc. (XBIO) · Fri 13 Nov 2026
Lifeward Q3 revenue falls 12% as AlterG grows and ReWalk moves to channel partners
🇺🇸 Lifeward Ltd. (LFWD) · Fri 13 Nov 2026